A Plethora of Innovative Products, to Help Make each Life Better
| Sr.No | Product Name | Strength | Dosage form | Dossier Readiness |
|---|---|---|---|---|
| 1 | Abiraterone Acetate | 250/500 mg | Tablets | Q1 2024 |
| 2 | Imatinib | 100/400 mg | Tablets | Q1 2024 |
| 3 | Dasatinib | 20/50/70/80/100/140 mg | Tablets | Q2 2024 |
| 4 | Axitinib | 1/5 mg | Tablets | Q2 2024 |
| 5 | Lenalidomide | 5/10/15/20/25 mg | Capsules | Q3 2024 |
| 6 | Pazopanib | 200/400 mg | Tablets | Q3 2024 |
| 7 | Nilotinib | 50/150/200 mg | Capsules | Q3 2024 |
| 8 | Ibrutinib | 140/280/420/560 mg | Tablets | Q2 2024 |
| 9 | Ibrutinib | 140 mg | Capsules | Q2 2024 |
| 10 | Palbociclib | 75/100/125 mg | Tablets | Q3 2024 |
| 11 | Palbociclib | 75/100/125 mg | Capsules | Q2 2024 |
| 12 | Enzalutamide | 40/80 mg | Tablets | Q3 2024 |
| 13 | Regorafenib | 40 mg | Tablets | Q2 2025 |
| 14 | Capecitabine | 50/150/300 mg | Tablets | Q3 2024 |
| 15 | Ruxolitinib | 5/10/15/20/25 mg | Tablets | Q4 2024 |
| 16 | Pomalidomide | 1/2/3/4 mg | Capsules | Q4 2024 |
| 17 | Lenavtinib | 4/10 mg | Capsules | Q4 2024 |
| 18 | Sunitinib | 12.5/25/37.5/50 mg | Capsules | Q4 2024 |
| 19 | Azathioprine | 50/75/100 mg | Tablets | Q4 2024 |
| 20 | Temozolomide | 5/20/100/140/180/250 mg | Capsules | Q1 2025 |
| 21 | Afatinib | 20/30/40 mg | Tablets | Q2 2025 |
| 22 | Crizotinib | 200/250 mg | Capsules | Q2 2025 |
| 23 | Bosutinib | 100/500 mg | Tablets | Q1 2025 |
| 24 | Cabozantinib | 20/40/60 mg | Tablets | Q1 2025 |
| 25 | Tacrolimus IR | 0.5/1/5 mg | Capsules | Q3 2025 |
| 26 | Olaparib | 100/150 mg | Tablets | Q3 2025 |
| Sr.No | Product Name | Strength | Dosage form | Dossier Readiness |
|---|---|---|---|---|
| 1 | Apixaban | 2.5/5 mg | Tablets | Available |
| 2 | Celecoxib | 100/200 mg | Capsules | Available |
| 3 | Dapagliflozin | 5/10 mg | Tablets | Available |
| 4 | Rivaroxaban | 2.5/10/15/20 mg | Tablets | Available |
| 5 | Sitagliptin Hydrochloride | 25/50/100 mg | Tablets | Available |
| 6 | Sitagliptin Hydrochloride + Metformin | 50 mg + 850 mg 50 mg + 1000 mg | Tablets | Available |
| 7 | Sitagliptin Phosphate | 25/50/100 mg | Tablets | Available |
| 8 | Sitagliptin Phosphate + Metformin IR | 50/500 mg 50/850 mg 50/1000 mg | Tablets | Available |
| 9 | Zolpidem | 5/10 mg | Tablets | Available |
| 10 | Clobazam | 10 mg | Tablets | Available |
| 11 | Metformin XR | 500/800/1000 mg | Tablets | Q1 2024 |
| 12 | Sitagliptin Phosphate + Metformin XR | 50 mg+ 500 mg / 50 mg + 1000 mg / 100 mg + 1000 mg | Tablets | Q2 2024 |
| 13 | Ticagrelor | 60/90 mg | Tablets | Q2 2024 |
| 14 | Vildagliptin | 50 mg | Tablet | Q2 2024 |
| 15 | Dabigatran | 75/110/150 mg | Tablets | Q2 2024 |
| 16 | Budesonide | 3 mg | Tablet | Q3 2024 |
| 17 | Mirabegron PR | 25/50 mg | Tablets | Q3 2024 |
| 18 | Acamprosate | 333 mg | Tablet | Q3 2024 |
| 19 | Dapaglifozin+ Metformin IR | 5 mg + 850 mg / 5 mg + 1000 mg | Tablets | Q4 2024 |
| 20 | Carbamazepine | 100/200/400 mg | Tablets | Q4 2024 |
| 21 | Prochlorperazine | 5/10 mg | Tablets | Q4 2024 |
| 22 | Linagliptin + Metformin | 2.5mg + 1000 mg | Tablets | Q4 2024 |
| 23 | Empagliflozin + Metformin | 12.5mg + 1000 mg/ 12.5mg + 850 mg/ 5mg + 1000 mg/ 5mg + 850 mg/ 5mg + 500 mg | Tablets | Q4 2024 |
| 24 | Dapaglifozin + Metformin XR | 5 mg + 500 mg/ 10 mg + 500 mg/ 5 mg + 1000 mg/ 10 mg + 1000 mg | Tablets | Q4 2024 |
| 25 | Linagliptin | 5 mg | Tablets | Q4 2024 |
| 26 | Empaglifozin | 10/25 mg | Tablets | Q4 2024 |
| 27 | Viladagliptin+Metformin | 50 + 500 mg / 50 +1000 mg | Tablets | Q4 2024 |
| 28 | Emaglifozin +Linagliptin | 10 mg + 5 mg/ 25 mg + 5 mg | Tablets | Q4 2024 |
| 29 | Dapaglifozin +Saxagliptin | 5 mg + 10 mg | Tablets | Q1 2025 |
| 30 | Saxagliptin + Metformin | 2.5 mg + 1000 mg/ 2.5 mg + 850 mg | Tablets | Q2 2025 |
| 31 | Saxagliptin | 2.5 mg / 5 mg | Tablets | Q2 2025 |
| 32 | Ezetimibe + Atorvastatin | 10 mg + 10 mg/ 10 mg + 20 mg/ 10 mg + 40 mg/ 10 mg + 80 mg | Tablets | Q2 2025 |
| 33 | Perindopril + Amlodipine | 5 mg + 5 mg / 5 mg + 10 mg/ 10 mg + 5 mg/ 10 mg + 10 mg | Tablets | Q4 2024 |
| Sr.No | Product | Strength | Dosage form | Dossier Readiness |
|---|---|---|---|---|
| 1 | Atorvastatin | 10 /20/40mg | Tablet | Available |
| 2 | Azithromycin | 500mg | Tablet | Available |
| 3 | Carvedilol | 25/12.5mg/6.25mg | Tablet | Available |
| 4 | Celecoxib | 200mg | Capsule | Available |
| 5 | Ciprofloxacin | 500 mg | Tablet | Available |
| 6 | Esomperazole | 20/40mg | Capsule | Available |
| 7 | Famotidine | 20/40mg | Tablet | Available |
| 8 | Ibuprofen | 400/600mg | Tablet | Available |
| 9 | Metformin | 850mg | IR Tablet | Available |
| 10 | Metformin | 500/750/1000mg | XR Tablet | Available |
| 11 | Metronidazole | 500mg | Tablet | Available |
| 12 | Paracetamol | 500mg | Tablet | Available |
| 13 | Pregabalin | 75/150mg | Capsule | Available |
| 14 | Sertralin | 50mg | Tablet | Available |
| 15 | Aripiprazole | 10/15mg | Tablet | Q4 2023 |
| 16 | Clobazam | 10mg | Tablet | Q4 2023 |
| 17 | Escitalopram | 10/20mg | Tablet | Q4 2023 |
| 18 | Ibuprofen | 200mg | Tablet | Q4 2023 |
| 19 | Losartan | 50mg | Tablet | Q4 2023 |
| 20 | Qutiepine | 100/25mg | Tablet | Q4 2023 |
| 21 | Memantine | 10/20mg | Tablet | Q1 2024 |
| 22 | Tranexamic Acid | 500mg | Tablet | Q1 2024 |
| 23 | Viladagliptin + Metformin | 50+500/ 50+1000mg | Tablet | Q1 2024 |
| 24 | Vildagliptin | 50mg | Tablet | Q1 2024 |
| 25 | Clonazepam | 2/0.5mg | Tablet | Q2 2024 |
| 26 | Desloratadine | 5mg | Tablet | Q2 2024 |
| 27 | Liveteracetam | 500/1000mg | Tablet | Q2 2024 |
| 28 | Montelukast | 10mg | Tablet | Q2 2024 |
| 29 | Resperidone | 1/3mg | Tablet | Q2 2024 |
| 30 | Tamsulosin | 0.4 mg | Capsule | Q2 2024 |
| 31 | Tamsulosin + Dutasteride | 0.4 +0.5 mg | XR Capsule | Q2 2024 |
| 32 | Tranexamic Acid | 500 mg | Tablet | Q2 2024 |
| 33 | Valproic acid EC | 200/250/500mg | EC Tablet | Q3 2024 |
| 34 | Valproic acid EC | 200/250/500mg | EC Tablet | Q3 2024 |